Signature Estate & Investment Advisors LLC Amarin Corp Plcuk Transaction History

Signature Estate & Investment Advisors LLC

$4.32 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 06, 2020	SELL	$13.94 - $24.12 $67,204 - $116,282	-4,821 Reduced 46.32%	5,586 $119,000
Q2 2019 Aug 01, 2019	BUY	$16.27 - $20.51 $7,923 - $9,988	487 Added 4.91%	10,407 $202,000
Q4 2018 Feb 01, 2019	BUY	$12.41 - $22.98 $18,615 - $34,470	1,500 Added 17.81%	9,920 $135,000
Q3 2018 Oct 18, 2018	BUY	$2.45 - $16.27 $20,629 - $136,993	8,420 New	8,420 $137,000

Others Institutions Holding AMRN

# of Institutions

176

Shares Held

65.1M

Call Options Held

258K

Put Options Held

98K

Sarissa Capital Management LP Greenwich, CT

24.9M
Shares

$15.7 Million
3.89% of portfolio
Kynam Capital Management, LP Princeton, NJ

12.4M
Shares

$7.82 Million
0.64% of portfolio
Eversept Partners, LP New York, NY

3.31M
Shares

$2.08 Million
0.16% of portfolio
Morgan Stanley New York, NY

2.55M
Shares

$1.6 Million
0.0% of portfolio
Scp Investment, LP

2.5M
Shares

$1.58 Million
1.16% of portfolio

View Full List

About AMARIN CORP PLCUK

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $254M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

More about AMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signature Estate & Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signature Estate & Investment Advisors LLC with notifications on news.

Account